Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection

NCT02506842 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Stage ⅠA Pancreatic Cancer
Stage ⅠB Pancreatic Cancer
Stage ⅡA Pancreatic Cancer
Stage ⅡB Pancreatic Cancer

Interventions

DRUG: nab-paclitaxel
DRUG: gemcitabine
DRUG: oxaliplatin
DRUG: folinic acid
DRUG: fluorouracil

Sponsor

Fudan University